New York-based Motif Bio plc said Robert Dickey IV resigned as CFO of the company.
Dickey, who assumed CFO duties January 2017, will continue to serve in an advisory capacity to ensure a smooth transition.
The biopharmaceutical company said it has started the search process for a new CFO, while its nonexecutive director Jonathan Gold has agreed to serve as interim CFO.
